Aytu BioScience Announces Closing of $12,000,000 Public Offering
06 Mar 2018 //
PR NEWSWIRE
Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Rights to Natesto
26 Apr 2016 //
PR NEWSWIRE
06 Mar 2018 //
PR NEWSWIRE
26 Apr 2016 //
PR NEWSWIRE